PRRT with Lu-177 DOTATATE in Treatment-Refractory Progressive Meningioma: Initial Experience from a Tertiary-Care Neuro-Oncology Center

20248 citationsJournal Articlehybrid Open Access

Authors

Ameya Puranik · Homi Bhabha National Institute

Indraja D. Dev · Homi Bhabha National Institute

Venkatesh Rangarajan · Homi Bhabha National Institute

Suyash Kulkarni · Homi Bhabha National Institute

Nitin Shetty · Homi Bhabha National Institute

Kunal Gala · Homi Bhabha National Institute

Arpita Sahu

Abstract

PRRT is a safe and effective therapeutic option for relapsed/refractory meningioma. The IA approach yields better dose delivery and should be routinely practised.

Topics & Keywords

Meningioma and schwannoma management Pituitary Gland Disorders and Treatments Head and Neck Surgical Oncology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Neurology India

Volume 72, Issue 2, pp. 278-284

DOI: 10.4103/ni.neurol-india-d-23-00252

Field-Weighted Citation Impact: 3.28